Machine Learning Surgo Health Study Offers New AI-Driven Insights into COVID-19 Vaccine Decision-Making PR Newswire May 18, 2023 Surgo Health, a new healthcare technology company dedicated to personalized healthcare,announced that original data and analysis from its…
Technology GeoVax Announces Expansion of Next-Generation COVID-19 Vaccine Rights to Include Omicron Variants… GlobeNewswire Apr 18, 2023 GeoVax Labs, a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced the expansion of its…
Machine Learning RAIsonance, Inc. Announces BARDA Contract to Continue Development of the AudibleHealth Dx Diagnostic… PRNewswire Apr 12, 2023 RAIsonance, the leader in artificial intelligence-powered analysis of FCV, announced it has been awarded a contract from the Biomedical Advanced…
Machine Learning AI Digital Tool Predicts Covid-19 Patient Prognosis AIT News Desk Nov 16, 2022 Feinstein Institutes for Medical Research scientists published in Nature Communications results of a two-and-a-half-year-long study using 35,000…
Machine Learning RECOVERY Trial Results Demonstrate Baricitinib Reduces Deaths In Hospitalised COVID-19 Patients AIT News Desk Sep 14, 2022 The University of Oxford team running the Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial, which recruited over 4,000 patients, have…
Healthcare Management University Of Miami Using Qynapse’s AI Technology To Research Effects Of Covid-19 On… AIT News Desk Sep 8, 2022 Qynapse Inc., a medical technology company with a commercialized Artificial Intelligence (AI) powered neuroimaging analysis platform for central…
Life Sciences Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune… AIT News Desk Jun 27, 2022 Pfizer Inc. and BioNTech SE announced positive data evaluating the safety, tolerability, and immunogenicity of two Omicron-adapted COVID-19 vaccine…
Healthcare Management New Data Highlight Immune Response to COVID-19 Vaccines in Individuals with Relapsing Forms of… AIT News Desk Jun 27, 2022 Bristol Myers Squibb announced new data on COVID-19 vaccine responses in participants treated with Zeposia (ozanimod) from the ongoing Phase 3…
Machine Learning Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19… AIT News Desk May 27, 2022 Insilico's candidate demonstrated a favorable profile with good in vivo efficacy at low doses, efficient synthesis, and no need for…
Life Sciences Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19… AIT News Desk May 26, 2022 EUA is based on data that show children 5 through 11 years of age had a robust immune response with a favorable safety profile following a 10-µg…